{"id":"W4404068475","doi":"10.1021/acsptsci.4c00512","title":"Repurposing Drugs and Synergistic Combinations as Potential Therapies for Inhibiting SARS-CoV-2 and Coronavirus Replication","year":2024,"lang":"en","type":"article","venue":"ACS Pharmacology & Translational Science","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Fonds de Recherche du Québec - Santé; Mitacs; Québec Consortium for Drug Discovery; Institut Pasteur; Institut national de la recherche scientifique; Armand-Frappier Foundation","keywords":"Drug repositioning; Repurposing; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Computational biology; Drug; Approved drug; Betacoronavirus; Coronavirus disease 2019 (COVID-19); Pandemic; Favipiravir; Biology; Drug discovery; Nelfinavir; 2019-20 coronavirus outbreak; Virology; Medicine; Pharmacology; Bioinformatics; Virus; Viral load; Infectious disease (medical specialty); Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005200868,0.0007241502,0.0009380754,0.0009993879,0.0003045047,0.0009699506,0.0004521212,0.0004029937,0.004404518],"category_scores_gemma":[0.0003536761,0.0002873671,0.0005842786,0.0005295582,0.0003468647,0.0007641413,0.0006218801,0.0009199564,0.0007226866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000408039,"about_ca_system_score_gemma":0.0004254999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002729407,"about_ca_topic_score_gemma":0.002306969,"domain_scores_codex":[0.9995735,0.0001122124,0.00003683838,0.00007916451,0.0001355462,0.00006269707],"domain_scores_gemma":[0.999848,0.00003281263,0.00003864913,0.00002377262,0.00002681278,0.00002994156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001226382,0.001195639,0.002125093,0.000671567,0.0001707855,0.0004452564,0.00008319793,0.002734097,0.8712355,0.001220462,0.001331335,0.1175607],"study_design_scores_gemma":[0.0007713158,0.0281022,0.008133836,0.0001499389,0.0006276922,0.002595261,0.0002554432,0.006472833,0.892377,0.001341896,0.05904726,0.0001253621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9300436,0.02937184,0.01450598,0.001338297,0.0002888567,0.001774275,0.00211346,0.000521767,0.02004205],"genre_scores_gemma":[0.9511037,0.01625308,0.02386437,0.0005591508,0.00009230753,0.000347284,0.001463952,0.00005878351,0.006257437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004404518,"threshold_uncertainty_score":0.01473457,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05843524321598349,"score_gpt":0.4281452466231933,"score_spread":0.3697100034072098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}